All, forgive me for harping on this so much, but when the deal is signed concerning China, shouldn’t this alone jump the PPS for GNBT quite a bit?

The reason I ask this is again Excellagan. Everything else is in trials or still being worked out, but this is an actual product that Generex has and can hit the ground running with.

I can’t remember what Joe estimated the revenue was for it in the US, but it would certainly be as much or more in China and probably other areas in Asia it might be used as well.

So, between all the deals that are being signed, this one deal already has a product line in place to be mass produced and sold on a wide scale.

When they see this and the fact that the product is in place for the VA hospitals...

That alone should garnish huge attention in the market and show Generex is a company worth getting into.